A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients Who Have Not Had Success With Amphotericin B

Not Applicable

Completed

• Conditions: Meningitis, Cryptococcal; HIV Infections

• Registration Number: NCT00002306
• Lead Sponsor: Pfizer

Brief Summary

To evaluate the safety and effectiveness of fluconazole as treatment for acute cryptococcal meningitis in patients who have had an unsatisfactory response to or have experienced unacceptable toxicity with amphotericin B.

Detailed Description

Not available

Study Timeline

• Status Verified: 1990-02
• Study First Submitted: 1999-11-02
• Study First Submitted QC: 2001-08-30
• Study First Posted: 2001-08-31
• Last Update Submitted: 2005-06-23
• Last Update Posted: 2005-06-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Trial Locations

Locations (14)

Univ of Alabama at Birmingham; 🇺🇸 Birmingham, Alabama, United States

George Washington Univ Med Ctr; 🇺🇸 Washington, District of Columbia, United States

Univ of South Florida; 🇺🇸 Tampa, Florida, United States

Emory Univ School of Medicine; 🇺🇸 Atlanta, Georgia, United States

Med College of Georgia; 🇺🇸 Augusta, Georgia, United States

Univ Hosp; 🇺🇸 Boston, Massachusetts, United States

Ann Arbor Veterans Administration Med Ctr; 🇺🇸 Ann Arbor, Michigan, United States

Washington Univ School of Medicine; 🇺🇸 St. Louis, Missouri, United States

Bronx Veterans Administration / Mount Sinai Hosp; 🇺🇸 Bronx, New York, United States

Saint Luke's - Roosevelt Hosp Ctr; 🇺🇸 New York, New York, United States

Scroll for more (4 remaining)